GeminIQ Website Logo

Viewing BNTC free

Subscribe for full history, 50+ metrics, screener, watchlist...

Benitec Biopharma Inc.

BNTC

Companies in Pharmaceutical Preparations

Benitec Biopharma Inc. (BNTC) — SEC Financial Statements & Analysis

Benitec Biopharma Inc. (BNTC) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
1851899498104786851-20262
Due From Banks
-------5114--2
Restricted Cash Current
000000000000
Accounts And Other Receivables Net Current
000000000000
Prepaid Expense And Other Assets Current
110100010001
Assets Current
18619095991047968521421264
Property Plant And Equipment Net
000000000000
Deposit Assets
000000000000
Prepaid Expense And Other Assets Noncurrent
000000000000
Operating Lease Right Of Use Asset
111110000001
Assets
187191961001057969521521274
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Other Accrued Liabilities Cur…
221162443543
Employee Related Liabilities Current
100001001100
Operating Lease Liability Current
000000000000
Liabilities Current
332273553654
Operating Lease Liability Noncurrent
01001--00000
Liabilities
432283553654
Stockholders Equity
Preferred Stock Value
000000-0----
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
445437331326310279260238197197197169
Retained Earnings Accumulated Deficit
-261-249-237-228-212-203-195-190-185-181-174-168
Accumulated Other Comprehensive Income Loss Net Of…
-1-1-1-1-1-1-1-1-1-1-1-1
Stockholders Equity
1831879497987664471215220
Liabilities And Stockholders Equity
187191961001057969521521274
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
480480480480480480480480480480480480
Common Stock Shares Issued
343426262623363027262530
Shares Outstanding
343426262623182022212030
Preferred Stock Par Or Stated Value Per Share
000000-0----
Preferred Stock Shares Authorized
555555-5----
Preferred Stock Shares Issued
000000-0----
Preferred Stock Shares Outstanding
000000-0----

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20263.19%-4.37%-7.45%0.00%-3.70%5.38%-10.97%11.56%----
20257.98%16.35%10.48%15.47%9.51%33.78%17.82%-3.02%-19.29%15.84%-2.59%-11.32%
2024-5.49%-5.49%-18.64%71.52%95.37%213.92%-8.62%14.41%-1.35%30.60%21.50%33.90%
2023------8.88%14.95%-39.53%15.59%15.93%10.85%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
56.82
67.69
46.95
54.67
14.80
25.48
15.01
10.49
4.18
3.62
5.83
0.94
Quick Ratio
56.47
67.49
46.72
54.32
14.75
25.36
14.92
10.39
4.13
3.56
5.72
0.64
Working Capital
182.74M
186.79M
93.05M
96.72M
96.98M
75.62M
63.78M
46.75M
10.93M
15.05M
21.88M
-249.00K
Leverage & Debt
Debt to Equity
0.02
0.02
0.03
0.02
0.08
0.04
0.07
0.11
0.30
0.38
0.21
21.10
Interest Coverage TTM
-9.26
-11.35
-12.40
-12.71
-11.82
-11.18
-14.61
-24.03
-895.50
-803.41
-679.17
-578.21
Debt Ratio
0.02
0.02
0.03
0.02
0.07
0.04
0.07
0.10
0.23
0.28
0.18
0.95
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
Per Share Metrics
Diluted EPS TTM
-0.84
-0.96
-1.01
-1.05
-0.88
-0.63
-0.75
-1.18
-1.19
-1.21
-1.35
-2.02
Free Cash Flow Per Share TTM
-0.40
-0.40
-0.54
-0.65
-0.48
-0.59
-0.70
-1.07
-1.12
-1.00
-1.23
-1.86
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-
-
-
-
-
-
-
-
-307,028.57%
-35,560.66%
-27,166.67%
-25,441.33%
Net Profit Margin TTM
-
-
-
-
-
-
-
-
-309,885.71%
-35,754.10%
-27,230.67%
-26,082.67%
Growth Metrics
Net Revenue Growth (1Y)
-
-
-
-
-100.00%
-100.00%
-100.00%
-100.00%
-89.71%
-1.61%
2.74%
2.74%
Net Income Growth (1Y)
22.79%
86.82%
100.53%
74.32%
55.97%
8.25%
2.12%
11.19%
8.63%
15.73%
11.87%
7.44%
EPS Growth (1Y)
-4.03%
51.40%
34.67%
-11.59%
-26.13%
-47.60%
-44.70%
-41.27%
-31.54%
-27.17%
-0.65%
11.80%
Valuation Metrics
P/E TTM
-12.66
-14.04
-13.93
-11.17
-14.84
-19.93
-12.29
-5.90
-4.42
-2.67
-2.23
-2.01
P/B
2.87
3.30
6.22
4.35
5.15
6.20
3.99
2.72
8.35
3.77
2.05
195.12
P/S TTM
-
-
-
-
-
-
-
-
13,711.42
954.94
608.41
525.52
Market Cap
525.96M
619.22M
582.54M
423.65M
502.18M
470.53M
256.25M
128.37M
95.98M
58.25M
45.63M
39.41M
Enterprise Value
341.09M
430.32M
487.95M
325.79M
398.73M
392.18M
188.35M
137.92M
81.82M
37.86M
19.75M
36.92M
Calculated Values
Free Cash Flow TTM
-19.82M
-18.44M
-22.37M
-23.61M
-18.69M
-21.94M
-19.59M
-19.58M
-20.39M
-18.07M
-18.55M
-18.01M
Net Debt
-184.88M
-188.90M
-94.59M
-97.86M
-103.45M
-78.35M
-67.91M
9.56M
-14.16M
-20.39M
-25.88M
-2.49M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-12-29Purchase
Owner: Cowen, Aaron, Averill Mas…
Title: -
Shares: 77,387
Price/Share: $13.44
Value: $1,040,081.28
Shares Owned: 9,700,195
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-12-19Purchase
Owner: Averill, Madison Master F…
Title: -
Shares: 16,384
Price/Share: $11.48
Value: $188,088.32
Shares Owned: 9,560,825
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-11-07Purchase
Owner: Suvretta, Capital Managem…
Title: -
Shares: 1,481,481
Price/Share: $13.50
Value: $19,999,993.50
Shares Owned: 9,538,175
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-03-31Purchase
Owner: Suvretta, Capital Managem…
Title: -
Shares: 16,497
Price/Share: $12.92
Value: $213,141.24
Shares Owned: 8,807,805
Relationship: TenPercentOwner
Ownership: Indirect
2025-03-26Purchase
Owner: Cowen, Aaron, Averill Mas…
Title: -
Shares: 900,000
Price/Share: $13.00
Value: $11,700,000.00
Shares Owned: 8,793,245
Relationship: Director,TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
65.57%
Inst. Shares: 32,384,836
Shares Outstanding: 49,386,203
2025-12-31
68.83%
Inst. Shares: 31,640,135
Shares Outstanding: 45,970,516
2025-09-30
55.77%
Inst. Shares: 23,154,724
Shares Outstanding: 41,521,280
2025-06-30
62.34%
Inst. Shares: 22,571,914
Shares Outstanding: 36,209,271
2025-03-31
53.58%
Inst. Shares: 20,679,905
Shares Outstanding: 38,599,453

Research Faster.
Invest Smarter.

Benitec Biopharma Inc. (BNTC) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.